High Tower Advisors, LLC Accelerate Diagnostics, Inc Transaction History

High Tower Advisors, LLC

$64.2 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.51 - $17.1 $4,080 - $136,800	8,000 Added 22.38%	43,740 $31,000
Q2 2022 Aug 10, 2022	SELL	$0.54 - $1.41 $843 - $2,202	-1,562 Reduced 4.19%	35,740 $36,000
Q1 2022 May 12, 2022	BUY	$1.4 - $5.15 $28,000 - $103,000	20,000 Added 115.59%	37,302 $53,000
Q4 2021 Feb 10, 2022	BUY	$4.27 - $6.97 $1,707 - $2,788	400 Added 2.37%	17,302 $91,000
Q3 2021 Nov 12, 2021	SELL	$5.31 - $8.25 $54,204 - $84,216	-10,208 Reduced 37.65%	16,902 $98,000
Q2 2021 Aug 06, 2021	BUY	$6.81 - $9.23 $184,619 - $250,225	27,110 New	27,110 $217,000
Q1 2020 May 21, 2020	SELL	$4.62 - $18.74 $49,937 - $202,560	-10,809 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.6 - $18.13 $157,811 - $195,967	10,809 New	10,809 $183,000
Q3 2019 Nov 12, 2019	SELL	$16.62 - $23.92 $210,857 - $303,473	-12,687 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$17.79 - $22.88 $50,078 - $64,407	2,815 Added 28.51%	12,687 $289,000
Q1 2019 May 15, 2019	BUY	$11.76 - $22.15 $116,094 - $218,664	9,872 New	9,872 $207,000
Q4 2018 Feb 14, 2019	SELL	$10.42 - $21.94 $109,222 - $229,975	-10,482 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$20.4 - $24.6 $12,444 - $15,006	610 Added 6.18%	10,482 $240,000
Q2 2018 Aug 14, 2018	SELL	$19.02 - $24.95 $13,028 - $17,090	-685 Reduced 6.49%	9,872 $220,000
Q1 2018 May 15, 2018	BUY	$22.55 - $29.9 $27,060 - $35,880	1,200 Added 12.82%	10,557 $241,000
Q4 2017 Feb 14, 2018	BUY	$18.0 - $30.0 $168,426 - $280,710	9,357 New	9,357 $246,000
Q3 2017 Nov 14, 2017	SELL	$21.1 - $25.15 $173,547 - $206,858	-8,225 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	8,225	8,225 $226,000

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account